These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10376646)

  • 21. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Special drug communication teleconference. August 7, 1992.
    Ear Nose Throat J; 1992 Sep; 71(9):383-4, 387-90. PubMed ID: 1425376
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
    Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
    Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
    Hampel FC; Kittner B; van Bavel JH
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):549-54. PubMed ID: 18219837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of second generation histamine antagonists on the heart].
    Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
    Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terfenadine and SSRIs.
    Tafler G
    CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
    [No Abstract]   [Full Text] [Related]  

  • 29. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
    Day JH; Briscoe MP; Welsh A; Smith JN; Clark A; Ellis AK; Mason J
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes.
    Hove-Madsen L; Llach A; Molina CE; Prat-Vidal C; Farré J; Roura S; Cinca J
    Eur J Pharmacol; 2006 Dec; 553(1-3):215-21. PubMed ID: 17078945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
    Simons FE; Johnston L; Gu X; Simons KJ
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):44-50. PubMed ID: 11206237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QT prolongation on the standard dose of astemizole.
    Gowardman J
    N Z Med J; 1996 Feb; 109(1015):38. PubMed ID: 8606815
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced arrhythmia.
    Heist EK; Ruskin JN
    Circulation; 2010 Oct; 122(14):1426-35. PubMed ID: 20921449
    [No Abstract]   [Full Text] [Related]  

  • 36. Ventricular arrhythmias and nonsedating antihistamines.
    Suissa S
    Br J Clin Pharmacol; 2000 Apr; 49(4):379-80. PubMed ID: 10866487
    [No Abstract]   [Full Text] [Related]  

  • 37. Pustular exacerbation of psoriasis due to fexofenadine.
    Saraswat A; Saraswat M
    Clin Exp Dermatol; 2006 May; 31(3):477-8. PubMed ID: 16681618
    [No Abstract]   [Full Text] [Related]  

  • 38. The risk of life-threatening cardiovascular events with terfenadine.
    Burkhart GA; Freiman J
    Am J Cardiol; 1995 Jan; 75(2):213-4. PubMed ID: 7810513
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of fexofenadine on the early response to nasal allergen challenge.
    Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fexofenadine--progress in antihistamine therapy].
    Merk HF
    Hautarzt; 1997 Aug; 48(8 Suppl):8. PubMed ID: 9378648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.